Bank of Montreal
XERS icon

Bank of Montreal’s Xeris Biopharma Holdings XERS Stock Holding History

Bank of Montreal’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-103
Closed -$170 – 4456
2022
Q2 		$0 Buy
+103
New +$217 ﹤0.01% 4498
2021
Q2 		– Sell
-1,665
Closed -$8K – 4974
2021
Q1 		$8K Sell
1,665
-135,818
-99% -$733K ﹤0.01% 4477
2020
Q4 		$789K Buy
137,483
+134,996
+5,428% +$675K ﹤0.01% 2411
2020
Q3 		$14K Sell
2,487
-513
-17% -$2.05K ﹤0.01% 3998
2020
Q2 		$8K Buy
+3,000
New +$10.4K ﹤0.01% 4287
2020
Q1 		– Sell
-3,385
Closed -$24K – 4783
2019
Q4 		$24K Buy
3,385
+1,050
+45% +$8.67K ﹤0.01% 4224
2019
Q3 		$23K Buy
2,335
+93
+4% +$1.04K ﹤0.01% 4020
2019
Q2 		$26K Buy
+2,242
New +$23.5K ﹤0.01% 4040
2019
Q1 		– Sell
-94
Closed -$2K – 4794
2018
Q4 		$2K Buy
94
+48
+104% +$963 ﹤0.01% 4429
2018
Q3 		$1K Buy
+46
New +$998 ﹤0.01% 4613

Other funds holding XERS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Bank of Montreal's XERS Position: Q3 2022 in Review

Bank of Montreal sold out of Xeris Biopharma Holdings (XERS) in Q3 2022, closing a stake of 103 shares — an estimated $170 sold.

Bank of Montreal first reported a position in XERS in Q3 2018 and held it in 10 quarters. The position peaked at $789K in Q4 2020. 101 funds tracked by Wall St. Rank hold XERS as of Q3 2022.

  • Bank of Montreal reported no remaining Xeris Biopharma Holdings position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 103 Xeris Biopharma Holdings shares in Q3 2022, an estimated $170.
  • Bank of Montreal first reported a position in Xeris Biopharma Holdings in Q3 2018 and held it in 10 quarters.
  • Bank of Montreal's Xeris Biopharma Holdings position peaked at $789K in Q4 2020.
  • 101 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.